Citadel Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,100
Closed -$242K 15115
2021
Q4
$242K Sell
12,100
-7,500
-38% -$141K ﹤0.01% 11443
2021
Q3
$356K Sell
19,600
-53,000
-73% -$1.22M ﹤0.01% 10686
2021
Q2
$1.96M Sell
72,600
-200
-0.3% -$5.6K ﹤0.01% 6675
2021
Q1
$2.18M Sell
72,800
-27,800
-28% -$948K ﹤0.01% 6195
2020
Q4
$2.89M Buy
100,600
+67,900
+208% +$1.83M ﹤0.01% 4646
2020
Q3
$798K Buy
32,700
+21,500
+192% +$464K ﹤0.01% 6428
2020
Q2
$200K Sell
11,200
-13,600
-55% -$179K ﹤0.01% 8527
2020
Q1
$202K Sell
24,800
-70,900
-74% -$810K ﹤0.01% 7999
2019
Q4
$1.26M Buy
95,700
+31,500
+49% +$381K ﹤0.01% 5178
2019
Q3
$763K Buy
64,200
+45,200
+238% +$837K ﹤0.01% 6058
2019
Q2
$465K Buy
+19,000
New +$547K ﹤0.01% 6937

Other funds holding CVET

Citadel Advisors's CVET Position: Q4 2022 in Review

Citadel Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 2,455,847 shares — an estimated $51.3M sold.

Citadel Advisors first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $51.3M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Citadel Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 2,455,847 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $51.3M.
  • Citadel Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Citadel Advisors's Covetrus, Inc. Common Stock position peaked at $51.3M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.